Medications
Temorel Hard Capsule
TemoRel (Temozolomide) Hard Capsule (20mg or 100mg) is an imidazotetrazine alkylating agent with antitumor activity that is administered orally.
Approved Indications:
-
Newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment. -
Malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.